60 Degrees Pharmaceuticals
SXTP
5 hedge funds and large institutions have $479K invested in 60 Degrees Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.05% more ownership
Funds ownership: 0% → 0.05% (+0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CBT
Central Bank & Trust
Lexington,
Kentucky
|
+$810K |
| 2 |
Walleye Capital
New York
|
+$241K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$38.2K |
| 4 |
VF
Virtu Financial
New York
|
+$24.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.98K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CBT
1
Central Bank & Trust
Lexington,
Kentucky
| $346K | +$810K | +1,950 | New |
|
|
2
Walleye Capital
New York
| $103K | +$241K | +580 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $16.4K | +$38.2K | +92 | New |
|
|
VF
4
Virtu Financial
New York
| $11K | +$24.9K | +60 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2.22K | +$4.98K | +12 | New |
|
6
Wells Fargo
San Francisco,
California
| $7 | – | – | – |
|
SXTP Hedge Fund Activity: Q3 2023 in Review
5 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q3 2023, worth a combined $479K.
Buyers outnumbered sellers: 5 funds opened new SXTP positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Central Bank & Trust, opening a new position worth an estimated $810K.
- 5 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q3 2023, up from 0 in Q2 2023.
- Funds reported $479K of 60 Degrees Pharmaceuticals stock for Q3 2023.
- 5 funds opened new 60 Degrees Pharmaceuticals positions in Q3 2023 and 0 closed out, a net change of +5 holders.
- The largest 60 Degrees Pharmaceuticals buyer in Q3 2023 was Central Bank & Trust, an estimated $810K added.
Based on aggregated 13F filings for Q3 2023.